SERELIANA financials
A multi-period view of the public annual-account figures reported for SERELIANA, with comparable measures and links to available source documents.
Company overviewRegistry number
0686747231
Fiscal coverage
2024–2025
Public sources
cbso_bulk
Data updated
Jul 29, 2026
Financial evidence
Latest movements for SERELIANA
2025 versus 2024
- Operating line
- €49,283
- EBITDA
- €16,316
- Total assets
- €86,148
- Equity
- €17,516
-7.8%
+68.6%
+31.7%
+32.4%
EBITDA margin +33.1% · Equity ratio +20.3%
Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.